Press Release | 15.12.2021
A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health.
FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 3,000+ peer-reviewed publications and 140+ international guidelines.
Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide.
The non-invasive gold standard solution for comprehensive management of liver health
Enhancing FibroScan® liver disease assessment with biological markers.
The complete non-invasive solution for advanced liver disease management
Identification of advanced fibrosis in NAFLD patients
FibroScan® is the most effective and best screening test for the diagnosis of chronic liver disease.
The ability FibroScan® gives to painlessly and quickly locate a liver health risk to a person, which also is one of the world’s biggest silent killers is a no brainer. I have yet to have any person tell me they didn’t want to know, in fact the complete opposite almost everyone alters something in their lives to improve their own and families liver health.